CTTH - CTT Pharma Strengthens Vitamin Patent in USA
(TheNewswire)
Tampa, Florida, United States- TheNewswire - April 25,2022 - CTT Pharmaceutical Holdings, Inc.( OTC: CTTH) is announcingtoday that we have recently filed a patent application encompassingvitamin-containing orally administrable strips. Thecontinuation-in-part application stems from our previously granted USPatent for similar orally administrable strips and is, thus, based ontechnology already determined to be patentable by the United StatesPatent and Trademark Office. The strips have been developed to deliveragents such as vitamins for absorption by the oral mucosa. This patentcovers dissolvable strips containing vitamins from various sources.
CTT Pharma’s vitamin strips dissolve in your mouth inseconds, then enters the bloodstream, bypassing the digestive tractincluding the liver. This allows for fast onset, betterabsorption/bioavailability, and the ability to add/combine actives toour Vitamin strips, such as CBD, and Caffeine for example. CTT canalso make our strips with any color and any flavor.
“Strengthening our vitamin patent portfolio was animportant step for CTT. I look at our dissolvable vitamin strips asthe next evolution to traditional vitamin pills and gummies.Furthermore, CTT will look to monetize our patent pending technologywith a company in the United States by engaging nutraceuticalcompanies about our vitamin strips.” said Ryan Khouri, CEO of CTTPharma.
CTT Pharma will continue to update our shareholders asmore news becomes available.
Ryan Khouri - 813-606-0060
www.cttpharmaceuticals.com
Copyright (c) 2022 TheNewswire - All rights reserved.